Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
77
MIRM Quote, Financials, Valuation and Earnings
Last price:
$80.69
Seasonality move
:
3.77%
Day range:
$78.87 - $81.09
52-week range:
$36.88 - $82.58
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
8.72x
P/B ratio:
14.21x
Volume:
241.9K
Avg. volume:
763.2K
1-year change:
91.49%
Market cap:
$4.2B
Revenue:
$336.9M
EPS (TTM):
-$0.86
Earnings Data
Next earnings date for MIRM
Feb 25
2026
Most recent earnings per share
$0.05
Beat by $0.21
(Nov 4/2025)
Consensus Estimate
-$0.16
(Nov 4/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
MIRM Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/25/2026 | Q4 | $135.8M | -- | -- | -$0.07 | -- |
| 11/04/2025 | Q3 | $130.5M | $133M | $0.05 | -$0.16 | $0.21 |
| 08/06/2025 | Q2 | $108.1M | $127.8M | -$0.12 | -$0.33 | $0.22 |
| 05/07/2025 | Q1 | $98.4M | $111.6M | -$0.30 | -$0.27 | -$0.03 |
| 02/26/2025 | Q4 | $96.6M | $99.4M | -$0.49 | -$0.25 | -$0.25 |
| 11/12/2024 | Q3 | $82M | $90.4M | -$0.30 | -$0.45 | $0.15 |
| 08/07/2024 | Q2 | $75.1M | $77.9M | -$0.52 | -$0.46 | -$0.06 |
| 05/08/2024 | Q1 | $70.2M | $69.2M | -$0.54 | -$0.30 | -$0.23 |
| 02/28/2024 | Q4 | $67.9M | $69.6M | -$0.71 | -$0.22 | -$0.48 |
| 11/02/2023 | Q3 | -- | $47.7M | -$0.57 | -- | -- |
| 08/03/2023 | Q2 | -- | $37.5M | -$1.94 | -- | -- |
| 05/04/2023 | Q1 | -- | $31.6M | -$0.80 | -- | -- |
| 03/08/2023 | Q4 | -- | $27.9M | -$0.99 | -- | -- |
| 11/09/2022 | Q3 | -- | $18.8M | -$1.02 | -- | -- |
| 08/04/2022 | Q2 | -- | $17.5M | -$0.84 | -- | -- |
| 05/05/2022 | Q1 | -- | $12.9M | -$1.17 | -- | -- |
| 03/09/2022 | Q4 | -- | $3.1M | $1.88 | -- | -- |
| 11/15/2021 | Q3 | -- | $5M | -$1.55 | -- | -- |
| 08/05/2021 | Q2 | -- | $11M | -$1.45 | -- | -- |
| 05/06/2021 | Q1 | -- | -- | -$1.68 | -- | -- |
| 03/09/2021 | Q4 | -- | -- | -$1.43 | -- | -- |
| 11/12/2020 | Q3 | -- | -- | -$0.86 | -- | -- |
| 08/06/2020 | Q2 | -- | -- | -$0.93 | -- | -- |
| 05/07/2020 | Q1 | -- | -- | -$0.86 | -- | -- |
| 03/12/2020 | Q4 | -- | -- | -$0.78 | -- | -- |
| 11/06/2019 | Q3 | -- | -- | -$0.66 | -- | -- |
| 08/28/2019 | Q2 | -- | -- | -$0.59 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$0.26 | -- | -- |
Mirum Pharmaceuticals, Inc. Earnings Questions
-
How Much did Mirum Pharmaceuticals, Inc. Generate in Revenue Last Quarter?
Mirum Pharmaceuticals, Inc. reported $133M worth of top line sales in its most recent quarter.
-
Did Mirum Pharmaceuticals, Inc. Beat Earnings Last Quarter?
Mirum Pharmaceuticals, Inc. announced earnings per share of $0.05 which represents a beat of analyst forecast a -$0.16 per share.
-
Is Mirum Pharmaceuticals, Inc. Profitable?
Mirum Pharmaceuticals, Inc. reported $107.4M that represents $1.88 per share over the last quarter.
-
What is the Analyst Consensus for Mirum Pharmaceuticals, Inc. EPS Next Year?
Mirum Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$1.85 per share to -$1.42 per share next year representing a decrease of -79.54%.
-
When is Mirum Pharmaceuticals, Inc.'s Earnings Date?
Mirum Pharmaceuticals, Inc.'s next earnings date is February 25, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
